SCHEMBL1809720

SCHEMBL1809720

COc1ccc(C=Cc2cc3cc(C)ccc3o2)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.60
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
NQO2 P16083 2/20 0.48
CYP1A1 P04798 5/20 0.48
CYP1B1 Q16678 4/20 0.48
CYP1A2 P05177 2/20 0.48
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48
TUBB8 Q3ZCM7 1/20 0.48
TUBA3E Q6PEY2 1/20 0.48
TUBA1A Q71U36 1/20 0.48
TUBA1C Q9BQE3 1/20 0.48
TUBB6 Q9BUF5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809719 1.00 APP (0.60) APPMAOAMAOBNQO2CYP1A1
SCHEMBL1511856 0.89 APP (0.60) APPNQO2CYP1A1CYP1B1CYP1A2
SCHEMBL1511854 0.89 APP (0.60) APPNQO2CYP1A1CYP1B1CYP1A2
SCHEMBL1806823 0.88 APP (0.75) APPMAOAMAOBNQO2CYP1A1
SCHEMBL1806824 0.88 APP (0.75) APPMAOAMAOBNQO2CYP1A1
SCHEMBL1806967 0.87 APP (0.59) APPNQO2CYP1A1CYP1B1CYP1A2
SCHEMBL1806968 0.87 APP (0.59) APPNQO2CYP1A1CYP1B1CYP1A2
SCHEMBL1805757 0.85 APP (0.61) APPNQO2CYP1A1CYP1B1CYP1A2
SCHEMBL1808924 0.85 APP (0.61) APPMAOAMAOBNQO2CYP1A1
SCHEMBL1808925 0.85 APP (0.61) APPMAOAMAOBNQO2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2011-05-26 US claimed
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF APP, BACE1, PSEN1 APP 1/4885MAOA 107/4885MAOB 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.